Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M MacDonald

Showing results (11-20 of 187) with videos related to

Pageof 19
Sort By:
Pharmacoepidemiology and Drug Safety|April 10, 2004
Sample size for cohort studies in pharmacoepidemiologyA D McMahon, T M MacDonald
British Journal of Clinical Pharmacology|November 9, 2000
Design issues for drug epidemiologyA D McMahon, T M MacDonald
International Journal of Clinical Practice|January 6, 2000
Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacologyA C Leary, T M MacDonald
QJM : Monthly Journal of the Association of Physicians|November 15, 2000
Step test in hypertensionP O Lim, T M MacDonald
British Medical Journal (Clinical Research Ed.)|September 29, 1984
PsittacosisT M Macdonald, R A Clark
Drugs & Aging|August 1, 1996
Tolerability of topical NSAIDs in the elderly: do they really convey a safety advantage?J M Evans, T M MacDonald
Pharmacoepidemiology and Drug Safety|April 10, 2004
Misclassification and selection bias in case-control studies using an automated databaseJ M Evans, T M MacDonald
Drug Safety|February 15, 2000
Use of routine healthcare data in safe and cost-effective drug useC J Currie, T M MacDonald
British Journal of Clinical Pharmacology|March 12, 1999
Record-linkage for pharmacovigilance in ScotlandJ M Evans, T M MacDonald
Scottish Medical Journal|April 1, 1994
Left ventricular hypertrophy in hypertension--general and local trends in diagnosis and therapyP Clarkson, N Prasad, T M MacDonald
Pageof 19

Showing results (11-20 of 187) with videos related to

Sort By:
Pageof 19
Pharmacoepidemiology and Drug Safety|April 10, 2004
Sample size for cohort studies in pharmacoepidemiologyA D McMahon, T M MacDonald
British Journal of Clinical Pharmacology|November 9, 2000
Design issues for drug epidemiologyA D McMahon, T M MacDonald
International Journal of Clinical Practice|January 6, 2000
Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacologyA C Leary, T M MacDonald
QJM : Monthly Journal of the Association of Physicians|November 15, 2000
Step test in hypertensionP O Lim, T M MacDonald
British Medical Journal (Clinical Research Ed.)|September 29, 1984
PsittacosisT M Macdonald, R A Clark
Drugs & Aging|August 1, 1996
Tolerability of topical NSAIDs in the elderly: do they really convey a safety advantage?J M Evans, T M MacDonald
Pharmacoepidemiology and Drug Safety|April 10, 2004
Misclassification and selection bias in case-control studies using an automated databaseJ M Evans, T M MacDonald
Drug Safety|February 15, 2000
Use of routine healthcare data in safe and cost-effective drug useC J Currie, T M MacDonald
British Journal of Clinical Pharmacology|March 12, 1999
Record-linkage for pharmacovigilance in ScotlandJ M Evans, T M MacDonald
Scottish Medical Journal|April 1, 1994
Left ventricular hypertrophy in hypertension--general and local trends in diagnosis and therapyP Clarkson, N Prasad, T M MacDonald
Pageof 19